$GNPX Announces Plans to Present at Inaugural MicroCap Rodeo Investor Conference

$TGODF Provides Update on Credit Financing

TORONTO, Oct. 9, 2019  – The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) (TSX:TGOD) (US:TGODF), a leading producer of premium certified organic cannabis, announces that it is reviewing financing alternatives in order to complete construction at its facilities in Ancaster, Ontario and Phase 1a at Valleyfield, Quebec. As previously disclosed, the Company had been engaged in discussions for ordinary course commercial bank facilities and equipment leasing. However, due to changing market conditions, those sources of financing have been unavailable on acceptable terms within the timeframes required, leading the Company to commence a review of additional alternatives. The Company currently has no debt and $56.7 million in cash available in Canada, including $40.2 million in restricted cash allocated to capital expenditures.

Construction at Ancaster is largely complete with all grow rooms licensed by Health Canada and approximately 6 weeks left before substantial completion of the processing facility. The evidence package for this final component is expected to be submitted to Health Canada by the end of November for licensing. The Company will prioritize any financing secured to accelerate commercial production in order to ramp-up revenues. TGOD already has supply agreements in place with Alberta, British Columbia and Ontario, and plans to distribute nationally as production increases in 2020. Portfolio development is underway for Cannabis 2.0 with first phase of product launches scheduled for December 2019, including organic teas and infusers.

The Company may revise the construction schedule for its Ancaster and Valleyfield projects if it is unable to obtain sufficient financing on reasonable terms, within the required timeframe. There can be no assurance that this review will result in the completion of any financing transaction.

Ancaster Highlights

• Purpose-built facility designed specifically for premium organic cannabis cultivation and processing.
• All grow rooms complete and licensed by Health Canada with total annual production capacity for the site at 17,500 kg; first harvest from greenhouse scheduled for Q4 2019.
• Existing Health Canada licence for cultivation, sales, oil extraction and oil sales renewed until 2022
• EU-GMP certification underway to enable exports to Europe.
• Large scale organic cultivation combined with premium pricing expected to generate strong margins.
• Constructed to Leadership in Energy and Environmental Design (LEED) standards; certification expected upon completion.

Valleyfield Highlights

• World’s largest organic cannabis facility at 1,310,000 sq. ft. once completed; designed specifically for premium organic cannabis cultivation.
• Phased approach with planned annual production capacity for phase 1a of 65,000 kg; first harvest scheduled by end of Q1 2020.
• Total planned capacity of 185,000 kg once all phases are completed.
• Access to North America’s lowest power rates combined with automation will enable low-cost production.
• Large scale cultivation of premium organic cannabis expected to generate industry-leading margins.
• Constructed to Leadership in Energy and Environmental Design (LEED) standards; certification expected upon completion.

About The Green Organic Dutchman Holdings Ltd.
The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (US-OTC: TGODF) is a publicly traded, premium global organic cannabis company, with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. TGOD also has organic hemp CBD oil operations in Canada, and through its wholly owned subsidiary HemPoland distributes premium hemp CBD oil in the EU. The Company grows high quality, certified organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a planned capacity of 219,000 kg and is building 1,643,000 sq. ft. of cultivation and processing facilities across Canada, Denmark and Jamaica.

TGOD’s Common Shares and warrants issued under the indenture dated November 1, 2017 trade on the TSX under the symbol “TGOD” and “TGOD.WT”, respectively.

For more information on The Green Organic Dutchman Holdings Ltd., please visit www.tgod.ca.

Forward-Looking Information Cautionary Statement

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward looking statements in this release includes, but is not limited to, statements about construction and future production, statements about the potential to achieve positive EBITDA and level of gross margins, statements about timing of harvests, statement about the potential for financing facilities, statements about the completion of EU-GMP certification and LEED certification, statement about status of Health Canada licences, statement about the offering of any particular products by the Company in any jurisdiction and statements regarding the future performance of the Company. Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “should”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties (including market conditions) and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements, including those risk factors described in the Company’s most recently filed Annual Information Form available on SEDAR. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither the TSX nor the TSX’s Regulation Services Provider (as that term is defined in the policies of Toronto Stock Exchange) accept responsibility for the adequacy or accuracy of this release.

$POAI Continues to Innovate to Improve Outcomes for Cancer Patients

• POAI is leveraging the potential of AI and smart tumor profiling to predict tumor drug response
• TumorGenesis is developing innovative techniques for growing tumors in laboratory settings
• Helomics uses vital information from patients’ own living tumors to assist oncologists in selecting the most effective treatments

Predictive Oncology Inc. (NASDAQ: POAI) is harnessing the power of artificial intelligence (AI) and rich information from patients’ own tumors to improve outcomes for cancer patients. Predictive Oncology applies its proprietary smart tumor profiling and AI platform to extensive genomic and biomarker patient datasets in order to predict tumor drug response and improve clinical outcomes for cancer patients.

Last year, POAI, then known as Precision Therapeutics, formed TumorGenesis to focus on innovative ways to create improved patient derived (PDx) tumor models. Currently, TumorGenesis is working on developing new techniques for growing tumors in the lab to generate more relevant models of the tumors that can be used to test drugs for…

Read more »

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://nnw.fm/POAI

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

$GGBXF All Indications Point to Billion Dollar CBD Markets Should Continue to Skyrocket

October 8, 2019

Palm Beach, FL – October 8, 2019 – Industry reports all seem to agree on one thing: The cannabidiol (CBD) revolution will continue to rise. As consumers accept… and even demand more CBD products, the future is projected to continue to rise in years to come. Statista has reported that it expects that U.S. consumer sales of CBD will reach around 1.8 billion U.S. dollars by 2022. That would be a massive increase from around half a billion dollars in 2018. Grandview, on the other hand said that 2018 global CBD revenues were 1.34 billion and that they are projected to expand at a CAGR of 32.6% through 2015. It seems that both the US and global markets are positioned to continue to thrive. Grandview added that: “Increasing awareness regarding health benefits pertaining to cannabidiol consumption is projected to foster the growth. High demand for cannabidiol in pharmaceutical formulations owing to its healing properties is anticipated to bode well for the market in near future.   Active cannabis companies in the markets this week include Integrated Cannabis Company, Inc. (OTCQB: ICNAF) (CSE: ICAN), HEXO Corp. (NYSE: HEXO) (TSX: HEXO), Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF), Emerald Health Therapeutics, Inc. (TSX-V: EMH) (OTCQX: EMHTF), Ignite International Brands, Ltd. (CSE: BILZ) (OTCQX: BILZF).

“Growing hemp production along with rising demand for cannabidiol rich hemp biomass is projected to bolster the market growth. Increasing adoption of refined cannabidiol (CBD) products coupled with growing legalization of medical marijuana is expected to drive the product demand in extended run.  CBD skin care products include moisturizers and creams, cleansers, serums, oils, and sunscreens. Anti-aging properties and effectiveness for all skin types, including sensitive and acne-prone skin, is anticipated to drive the demand for cannabidiol in skin care and cosmetic products.”

Integrated Cannabis Company, Inc. (CSE:ICAN) (OTCQB:ICNAF) BREAKING NEWS:  Integrated Cannabis Company,  a multi-state brand operator in California and Nevada, is pleased to announce that its wholly-owned subsidiary, Ganja Gold, has launched the first cannabidiol (CBD) infused pre-roll in California.  The novel pre-roll is designed for those who want the calming effects and benefits of CBD and is part of the iconic Tarantula family of pre rolls.

The October launch includes several high CBD strain SKUs such as: Harley-Tsu (indica dominant), AC/DC (sativa dominant), The Wife (Hybrid). Additional strains will be launched in the coming months. The CBD Tarantula is constructed with top-shelf greenhouse or indoor grown flower that is then coated with high CBD distillate and covered in golden kief.

“The Ganja Gold legacy brand is synonymous with a top shelf, connoisseur level experience amongst consumers.  We are excited to be introducing our new line of CBD infused pre-rolls that are made to the same exacting standards that consumers are accustomed to from Ganja Gold, said Mr. Seth Wiles, President of Integrated Cannabis.  “We did extensive R&D to make sure this was a product that would strike a chord with our existing customers, as well as expand our reach in the market. Our goal is to launch products that will allow more cannabis users to experience our amazing brand. We plan to launch the CBD Tarantula along with our full line of Tarantulas in Nevada from our manufacturing facility in Las Vegas in the very near future,” added Mr.Wiles.

Other Companies with recent developments or to keep watch for in the cannabis industry include:

HEXO Corp. (NYSE: HEXO) (TSX: HEXO) recently announced that the company’s Chief Financial Officer, Michael Monahan, has made the decision to resign, effective Monday.   “Since joining HEXO Corp, it has become apparent that this job requires me to spend the majority of my time in Gatineau and in Ottawa. During this phase of rapid expansion, the Chief Financial Officer should be working very closely with all team members, in person. This isn’t possible for me at this time given my family’s needs and so I have decided to resign,” said Mr Monahan. “I’ve had a very rewarding time at HEXO and I will continue to assist the company as a consultant to ensure a smooth transition.”

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) recently announced that Jann Parish , Chief Marketing Officer, has been named to the Forbes CMO Next list. The list is comprised of 50 individuals who are leading the way as disruptive chief marketers.  Through qualitative research tapping into the expertise of industry watchers as well as Forbes’ editorial industry knowledge, the list features 50 people who have reached the highest-level marketing position within a given company and who are driving brand and business growth.

“I am honored and humbled to receive this recognition,” said Jann Parish , CMO of Green Growth Brands. “I am thrilled to be applying my expertise to the cannabis and CBD industries. At Green Growth Brands, we look at this moment in time as an opportunity to reinvent the way consumers view and interact with products that have very complicated histories. For Forbes to be considering our industry as part of this award speaks to the progress we have already made.”

Emerald Health Therapeutics, Inc. (TSX-V: EMH) (OTCQX: EMHTF) has received from Health Canada a license amendment for the complete growing and processing area in its 88,000 square foot indoor facility. The additional 50,000 square feet will allow Verdélite to expand production from 4 to 21 highly-controlled-environment grow rooms and to a total of 16 processing rooms. Planting in the newly licensed area is starting immediately, with the plan focused on having the expanded facility fully planted in eight weeks.

“Verdélite is now fully built and licensed across all its growing and processing areas, and I congratulate the team for this accomplishment,” said Thierry Schmidt, President of Verdélite. “As we expand production of Emerald Health Therapeutics products sold under the Emerald sales license, this step enables us to also continue advancing our marketing strategy encompassing Verdélite brands and direct sales to provincial/territorial wholesalers and authorized Canadian private retailers.”

Ignite International Brands, Ltd. (CSE: BILZ.CN) (OTCQX: BILZF) recently announced that it intends to complete a non-brokered private placement of convertible debenture units (the “Units”) for up to C$50 million (the “Offering”), issuable in series (each, a “Series”).  Each Unit is to be comprised of C$1,000 principal amount of unsecured senior convertible debentures (a “Convertible Debenture”) accruing interest at 8.0% per annum, payable semi-annually in arrears until maturity, and 250 subordinate voting share purchase warrants of the Company (each, a “Warrant”). The Convertible Debentures will have a maturity date of 36 months from the date of issuance.

DISCLAIMER:  FN Media Group LLC (FNM), which owns and operates Financialnewsmedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  FNM is NOT affiliated in any manner with any company mentioned herein.  FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  FNM is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.  For current services performed FNM has been compensated twenty five hundred dollars for news coverage of the current press releases issued by Integrated Cannabis Company, Inc. by the company.  FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

$CNPOF $RIV.V on View from the C-Suite Telling His Company’s Story

https://youtu.be/adG2c_r5M3c

The View from the C-Suite video interview series highlights the unique perspectives of listed companies on Toronto Stock Exchange and TSX Venture Exchange. Videos provide insight into how company executives think in the current business environment. To see the latest View from the C-Suite videos visit www.tmxmoney.com/en/news/csuite.html)

About Canopy Rivers Inc. (TSX: RIV)

Canopy Rivers is a venture capital firm specializing in cannabis. Its unique investment and operating platform is structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers identifies strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth Corporation (TSX: WEED, NYSE: CGC) and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem.

About TMX Group (TSX: X)

TMX Group’s key subsidiaries operate cash and derivative markets and clearinghouses for multiple asset classes including equities and fixed income. Toronto Stock Exchange, TSX Venture Exchange, TSX Alpha Exchange, The Canadian Depository for Securities, Montréal Exchange, Canadian Derivatives Clearing Corporation, Trayport and other TMX Group companies provide listing markets, trading markets, clearing facilities, depository services, technology solutions, data products and other services to the global financial community. TMX Group is headquartered in Toronto and operates offices across North America (Montréal, Calgary, Vancouver and New York), as well as in key international markets including London, Beijing and Singapore. For more information about TMX Group, visit our website at www.tmx.com. Follow TMX Group on Twitter: @TMXGroup.

$OGI California Cities and Counties Still Divided on Hemp Cultivation

$INMB to Present at major Upcoming Immunological Conferences

$LXRP Update on R&D Program Progress under License Agreement with Altria

Kelowna, British Columbia – October 8, 2019 – Lexaria Bioscience Corp. (OTC:LXRP) (CNSX:LXX.CN) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to provide this update on the ongoing relationship and pursuit of innovation in oral, reduced risk nicotine consumer products using Lexaria’s patented DehydraTECHTM technology, underway between Altria Ventures Inc., an indirect wholly owned subsidiary of Altria Group, Inc (NYSE:MO) (“Altria”) and Lexaria’s majority owned subsidiary Lexaria Nicotine LLC (“Lexaria Nicotine”).

Most of the investigation and work within this first phase of the project is either complete or significantly underway, with one remaining aspect ready to commence imminently. To date, results have been positive and are supportive of successfully completing this first phase.

Successful completion of phase one will be the first step in developing commercially viable products using Lexaria’s technology. The existing Altria Ventures Inc. and Lexaria Nicotine licensing agreement provides for royalties to be paid to Lexaria Nicotine on worldwide revenues from oral nicotine products sold, should Altria decide to utilize Lexaria’s patented DehydraTECHTM technology, whether in the US or around the world.

“The program between Altria and Lexaria is progressing nicely and is enabling a clearer understanding of the potential of delivering nicotine through oral forms that avoid lung absorption,” said Chris Bunka, CEO of Lexaria Bioscience and Lexaria Nicotine. “Lexaria strongly believes that, given the choice, many of the world’s one billion smokers would elect to experience their nicotine in a manner that does not rely on either smoking or vaping, and Lexaria can help enable these alternatives.”

Lexaria believes that oral forms of nicotine delivery can be a positive contributor to methods of reduced-risk access to nicotine with far superior health outcomes to traditional combustible cigarettes. In both human clinical studies and in animal studies, DehydraTECH has repeatedly demonstrated its ability to enhance the bio-absorption and bioavailability performance of beneficial compounds in ingestible products. Lexaria’s patented DehydraTECH technology could offer the world enhanced satisfactory oral nicotine delivery and usher in a new era of reduced-risk nicotine use through enhanced consumer choices.

About Lexaria

Lexaria Bioscience Corp. is a global innovator in drug delivery platforms. Its patented DehydraTECH(TM) drug delivery technology changes the way Active Pharmaceutical Ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. DehydraTECH increases bio-absorption; reduces time of onset; and masks unwanted tastes for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. Lexaria has licensed DehydraTECH to multiple companies in the cannabis industry for use in cannabinoid beverages, edibles and oral products; and to a world-leading tobacco producer for the development of smokeless, oral-based nicotine products. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 16 patents granted and over 60 patents pending worldwide.

www.lexariabioscience.com

For regular updates, connect with Lexaria on Twitter (https://twitter.com/lexariacorp)

and on Facebook https://www.facebook.com/lexariabioscience/

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Bioscience Corp.

Alex Blanchard, Communications Manager

(250) 765-6424 ext. 202

Or

NetworkNewsWire (NNW)

www.NetworkNewsWire.com

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements, including but not limited to: that any additional patent protection will be realized or that patent achievements will deliver material results. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation and regulatory approvals, managing and maintaining growth, the effect of adverse publicity, litigation, competition, scientific discovery, the patent application and approval process and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that existing capital is sufficient for the Company’s needs or that it will be able to raise additional capital. There is no assurance the Company will be capable of developing, marketing, licensing, or selling edible products containing nicotine or any other active ingredient. There is no assurance that any planned corporate activity, scientific research or study, business venture, letter of intent, technology licensing pursuit, patent application or allowance, consumer study, R&D project with Altria Group, Inc or any initiative will be pursued, or if pursued, will be successful or completed. There is no assurance that any of Lexaria’s postulated uses, benefits, or advantages for the patented and patent-pending technology will in fact be realized in any manner or in any part. No statement herein has been evaluated by the Food and Drug Administration (FDA). Lexaria-associated products are not intended to diagnose, treat, cure or prevent any disease.

$GNPX Pioneering Use of Non-Viral Vector Delivery for Gene Therapy Further Validated

$TGODF $TGOD.V Another Marijuana Legalization Bill Introduced in Mexico Legislature

October 7, 2019

On Tuesday, a key Mexican lawmaker introduced a new marijuana legalization bill in parliament. The legislation would allow people to cultivate marijuana in their homes.

The coordinator of the ruling MORENA party’s bench in the Deputies Chamber, Mario Delgado Carrillo, while filing the legislation, argued that regulating marijuana would help in promoting health among the Mexicans. Furthermore,  having the government in charge of the program would help in reducing industry monopolization by the big marijuana companies.

In the bill, he outlined the history of the marijuana ban in Mexico while citing that there is not enough evidence to support the ban. The prohibition of cannabis is repressive, and it violates the fundamental rights of the Mexicans. He also added that legal access to marijuana could be used to treat patients with certain conditions.

The bill also states that prohibition has led to widespread violence in Mexico through the formation and multiplication of criminal gangs. Furthermore, marijuana legalization would create jobs and stimulate growth in the Mexican economy.

As stated in the bill, the government would form a department called Cannsalud, which would be responsible for regulating the legal cannabis market. The department would be a branch of the federal government with technical, operational, and management roles to help in the realization of the sole purpose of the bill, marijuana legalization.

Last year, Mexican lawmakers went on a benchmarking trip to Canada to learn more about their marijuana legalization model. In Canada, marijuana is sold through government stores. It seems the Mexican lawmakers have adopted the Canadian system of the government-run approach to marijuana regulation.

The Mexican legislation would permit adults to cultivate a maximum of six marijuana plants for recreational use.

According to Delgado, the state would constantly supervise and control the growth and use of marijuana to make sure that it stays within the margin of legality, and the marijuana market is not left to the control of the citizens.

Under the bill, a public company would be formed as an intermediary to help identify and mitigate risks possible in the market; such as international companies maximizing their profits by utilizing weed above the legal potency limit, which would prove harmful to human health.

The Mexican Senate has been organizing events to promote talks about marijuana legalization for the past several weeks. A former White House drug czar was featured in one event where he urged the Mexican lawmakers to implement strong regulation for the cannabis market.

Earlier this month, Senator Julio Mencaca of the MORENA party introduced new marijuana legislation that does not call for the government to control sales.

Experts believe marijuana industry players, such as Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) and The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF), in other markets are watching to see which of these bills is eventually passed in Mexico.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

$CNPOF $RIV.V Significant Increase in Health Canada Licensed Infrastructure

TORONTO, Oct. 7, 2019 – Canopy Rivers Inc. (the “Canopy Rivers“) (TSX: RIV, OTC: CNPOF) today announced that its portfolio company, TerrAscend Corp. (“TerrAscend“) (CSE: TER, OTCQX: TRSSF) has received approval from Health Canada for a significant expansion at its Mississauga, Ontario facility. TerrAscend expects that this milestone will help the company meet the increased consumer demand for premium cannabis products and brands coming with the next wave of Canadian cannabis legalization. As the first and only cannabis company with sales in Canada, the U.S., and Europe, TerrAscend has also earmarked the additional capacity to further serve the global markets where it operates.

With this approval, TerrAscend’s licensed space nearly triples to 51,800 sq. ft. and includes additional cultivation capacity, a commercial kitchen, formulation rooms and increased primary and secondary packaging capacity. First licensed for cultivation in July 2017, TerrAscend’s 67,300 sq. ft. EU GMP certified indoor cannabis facility is focused on serving the Canadian medical and adult-use markets, conducting research & development for plant sciences and formulations, and serving as a platform for export of cannabis products to Europe and other international jurisdictions.

Canopy Rivers, along with Canopy Growth Corporation, first invested in TerrAscend in November 2017. In October 2018, both parties restructured their investment in TerrAscend. This restructuring enabled TerrAscend to pursue strategic international transactions in the cannabis space while ensuring all parties remained compliant with industry and securities regulations. More recently, Canopy Rivers announced an additional US $10 million investment in TerrAscend Canada Inc., a subsidiary of TerrAscend, cementing Canopy Rivers’ position that TerrAscend is an industry leader and a critical partner in the Canopy Rivers ecosystem.

About Canopy Rivers

Canopy Rivers is a venture capital firm specializing in cannabis. Its unique investment and operating platform is structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers identifies strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth Corporation (TSX: WEED, NYSE: CGC) and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem.

Forward-Looking Statements

This news release contains statements which constitute “forward-looking information” within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of Canopy Rivers with respect to future business activities and operating performance. Forward-looking information is often identified by the words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” or similar expressions and includes information regarding: the impact of the Health Canada approval on TerrAscend’s production capacity; TerrAscend meeting increased consumer demand for cannabis products globally; the growth of consumer demand with the next wave of Canadian cannabis legalization; TerrAscend’s focus for its indoor facility; management’s view of TerrAscend’s position and partnership in the Canopy Rivers ecosystem; and expectations for other economic, business, and/or competitive factors.

Investors are cautioned that forward-looking information is not based on historical fact but instead reflects management’s expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although Canopy Rivers believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of Canopy Rivers. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: regulatory and licensing risks; the actual impact of the Health Canada approval on TerrAscend’s production capacity and the use of its space; changes in consumer demands and TerrAscend’s ability to meet such demands globally, including with the next wave of cannabis legalization; changes in general economic, business and political conditions, including changes in the financial markets; the global regulatory landscape and enforcement related to cannabis, including political risks and risks relating to regulatory change; risks relating to anti-money laundering laws; compliance with extensive government regulation; public opinion and perception of the cannabis industry; and the risk factors set out in Canopy Rivers’ annual information form dated July 15, 2019, filed with the Canadian securities regulators and available on Canopy Rivers’ profile on SEDAR at www.sedar.com.

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although Canopy Rivers has attempted to identify important risks, uncertainties and factors that could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. Canopy Rivers does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.

$OGI Representative Assumes Board Positions w/ Key Cannabis Industry Orgs.

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, today announced that a representative of the company has assumed board positions with three international organizations committed to promote and foster global cannabis industry growth. According to the update, Organigram’s Vice President of Public Affairs and Stakeholder Relations (North America), Cameron Bishop, has assumed board seats on The American Trade Association for Cannabis and Hemp, The Policy Center for Public Health & Safety (both U.S.-based) and the European Alliance for Medical Cannabis, as well as a board chair position on the European Alliance for Medical Cannabis’ Access, Innovation and Research Committee. Bishop was also recently appointed vice-chair of the Cannabis Council of Canada (“C3”), Canada’s national organization of licensed producers. “I’m proud to represent Organigram and the legal cannabis industry in Canada as a board member for these organizations. Reforming cannabis laws, breaking down barriers of prohibition and building new economic engines takes time, dedication and experience,” Bishop said in the news release. “These groups embody those elements; I’m confident the work we do together will lead to lasting benefits for cannabis, industry, consumers and patients here at home and around the world.”

To view the full press release, visit http://cnw.fm/e3F7l

About Organigram Holdings Inc.

Organigram Holdings Inc. is a NASDAQ Global Select and TSX listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada. Organigram is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the company’s global footprint. Organigram has also developed a portfolio of legal adult use recreational cannabis brands including The Edison Cannabis Company, Ankr Organics, Trailer Park Buds and Trailblazer. Organigram’s primary facility is located in Moncton, New Brunswick and the company is regulated by the Cannabis Act and the Cannabis Regulations (Canada). For more information, visit the company’s website at www.Organigram.ca.

NOTE TO INVESTORS: The latest news and updates relating to OGI are available in the company’s newsroom at http://cnw.fm/OGRMF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

$GWPD Trading to Recommence October 17, 2019

CORONA, Calif., Oct. 7, 2019 — GP Solutions, Inc. (OTC: GWPD) announces today that trading of the Company’s common stock on the OTC Pinks is expected to recommence at the opening of the market on October 17, 2019. The SEC had issued a 10-day temporary trading suspension on October 3^rd under Section 12(k) of the Exchange Act citing its concerns about (1) the adequacy and reliability of publicly available information concerning the Company, including a certain social media post issued by the Company; and (2) possible manipulative trading in the Company’s stock, including certain transactions executed between March 12 and August 27, 2019.

The Company has reached out to the SEC’s New York Regional Office to address and resolve these concerns.

The Company is confident that it has fully complied with providing investors “current information” as required by with Rule 15c2-11 of the Exchange Act by meeting OTC Links’ Alternative Reporting Standards, including, but not limited to, filing annual and quarterly disclosure statements on the OTC Markets’ website as well as an annual Attorney Letter opining that the information posted by the Company on the OTC Markets News Service includes all of the information that a broker dealer would be required to obtain from the Company to publish a quotation for the Company’s securities under Rule 15c2-11 of the Exchange Act and complies as to form with the OTC Markets Guidelines for Providing Adequate Current Information. On September 20^th, the Company filed a Form 1-A for a Reg A+ Tier 2 offering with the SEC containing audited financial statements for years ended December 31, 2018 and 2017 and which is currently being reviewed by the SEC.

“We respect the Commission and look forward to resolving any issues expeditiously and effectively. This is a unfortunate but temporary bump in the road for our company and shareholders,” commented George Natzic, CEO. Natzic continued, “Maintaining a high standard of transparency and clarity not only for our shareholders but for the investment community in general has always been and remains our highest priority.”

About GP Solutions, Inc.

GP Solutions, Inc. provides a state of-the-art, environmentally optimized growing system for growing high quality specialty crops, specifically leaf crops, including many varieties of herbs. GP Solutions’ standalone soil and hydroponic system contains everything needed to grow fresh produce, giving GP Solutions’ customers the flexibility of location. GP Solutions’ system can be placed anywhere with power and potable water, providing growers easy access to the harvest. With a Grow Pod, the GP Solutions is “Desert-to-Arctic” ready and optimized for high yield. Pods from GP Solutions are ready and optimized for year around production. With Grow Pod produce can be grown on-site, virtually eliminating the expensive and lengthy supply chain that generally exists between the farmer and the consumer. GP Solutions systems can be configured with solar power and water re-capturing systems. GP Solutions has developed a virtually sealed environment that can be completely self-sufficient off the grid.

Cautionary Note Regarding Forward-Looking Statements

This release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “believe,” “project,” “estimate,” “expect,” “future,” “likely,” “may,” “should,” “will” and similar references to future periods. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements.

Any forward-looking statement made by us in this release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Contact:

Email: info@growpodsolutions.com
Website: www.growpodsolutions.com
Facebook: facebook.com/GrowPodTechnology
Twitter: @GrowPodSolution

$GGBXF Ambitious Expansion, Big-Name Partnerships Fueling Cannabis Industry Growth

Oct 7, 2019

It would have been almost impossible to predict, just a few years ago, how big the cannabis space would be by now. Recent legislative decisions from both the United States and Canadian governments have led to a booming industry, one that supports dozens of companies vying for a share of cannabis profits. The recent downturn in the market, however, shows that not every company will survive the industry’s infancy and prove profitable in the long run. Investors need to consider which cannabis and CBD companies have plans to establish themselves as broadly and as firmly as they can, particularly in the retail sector. Companies that are implementing these plans—like Green Growth Brands Inc. (CSE:GGB) (OTC:GGBXF) (GGB or the Company), Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF), HEXO Corp. (TSX: HEXO) (NYSE: HEXO), MedMen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF), and OrganiGram Holdings (TSXV: OGI) (NASDAQ: OGI)—are cementing a place for themselves in the cannabis space, and are likely to provide long-term profits for shareholders.

Green Growth Brands’ Rapid Expansion with Seventh Sense

Green Growth Brands Inc. (CSE:GGB) (OTC:GGBXF) has been doing a better job of establishing itself as a retail powerhouse than perhaps any other cannabis company. GGB is remarkable amongst its contemporaries for having the strongest sales per square feet in the entire industry and is continuing to expand at an ambitious rate.

On October 3, Green Growth Brands opened its 150th Seventh Sense Botanical Therapy CBD shop. This milestone achievement would be impressive for any cannabis company, but it’s especially impressive for GGB considering it only opened its first Seventh Sense store less than nine months ago.

The first shop opened in Lexington, Kentucky on February 13. Since then, Green Growth Brands has spread its retail footprint to 150 stores across 35 American states. The company has no plans to rest on its laurels, however, as it expects to open a total of 200 retail locations by the start of the 2019 holiday shopping season.

But it’s not just the number of stores that makes the Ohio-based company’s future so encouraging. It’s also the impressive marketing strategies and the customer loyalty it’s been able to foster.

Green Growth Brands Inc. (CSE:GGB) (OTC:GGBXF) has found that, to date, nearly 20% of customers in its consumer database have chosen to make a repeat purchase. On top of that, online purchases occur, on average, every 31 days. This appreciation that Seventh Sense customers have for the brand is further highlighted by the fact that more than 350 product reviews online provide an average rating of 4.5 stars out of 5.

Over the month of August, the Seventh Sense email consumer database grew by 59%. That same month, GGB launched an SMS texting initiative for its customers, and in the last 30 days enrollment for the messaging service has risen 178%.

Clearly the retail brand’s outreach efforts are being reciprocated by its customers. To capitalize further, Seventh Sense is launching its first national media campaign this October, which will focus heavily on digital and branded media partnerships. As part of this campaign, the company will commission editorial-focused media placements and unique out-of-home activations in key markets throughout the US.

Through the two-pronged approach of swiftly increasing its retail footprint in malls all over America and optimizing its digital reach to customers, Green Growth Brands (CSE:GGB) (OTC:GGBXF) is proving that it deserves its position as a leading name in the cannabis and CBD industry. Current investors, and those interested in investing, can look forward to the company’s Q4 financial results which will be released on October 23.

Green Growth Brands’ Contemporaries

Though Green Growth Brands’ remarkable growth is unparalleled, the company doesn’t stand alone in the cannabis space.

This year, Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF) has been making incredible strides to establish itself as a major player in cannabis and CBD retail. In March, CVS Health Corp.—the largest drugstore chain in the US by total sales—began carrying Curaleaf’s line of CBD products.

Plus, with 49 dispensaries across the nation, the company currently has the largest dispensary footprint in the US. And it’s still increasing all the time.

Likewise, one of the largest licensed cannabis companies in Canada, HEXO Corp. (TSX: HEXO) (NYSE: HEXO) has been extending its cannabis products across the country, and even into Europe, by partnering with Fortune 500 companies.

One such company is Molson Coors Brewing Company, which is partnering with HEXO to launch cannabis-infused beverages. This deal could propel HEXO towards a global cannabis drinks expansion, a market that analysts believe could be worth $5 billion by 2026.

Trailing just a little behind in terms of retail capacity, MedMen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) recently opened its 27th, 28th, and 29th retail locations. With this news, the company now has four operational stores in the state of Florida, and is planning to open eight additional stores there before the end of 2019.

On top of that, MedMen is licensed for a total of 35 retail locations in the state. Based on its potential expansion, analysts remain bullish on the company.

Finally, no discussion of impressive growth in the cannabis retail sector would be complete without bringing up OrganiGram Holdings (TSX: OGI) (NASDAQ: OGI). The New Brunswick-based company is one of only three LPs that have distribution agreements in all 10 provinces across Canada.

In growing from a regional cannabis player to a nation-wide powerhouse, OrganiGram has amassed a portfolio of legal adult use recreational cannabis brands. In recent months, the company’s revenue has been soaring, and in August OGI stock began listing on the TSX.

Partnerships Are Critical for Cannabis Companies

As companies like HEXO and Curaleaf have made clear, partnerships with popular, name-recognizable brands are one of the best ways for cannabis retailers to establish themselves. In this regard, Green Growth Brands Inc. (CSE:GGB) (OTC:GGBXF) continues to go above and beyond.

In January, the company made an agreement with shoe company DSW Inc. to sell hemp-derived CBD personal care products under the Seventh Sense Botanical Therapy brand in 96 DSW stores throughout the US. The agreement is for 54,960 units—which include muscle balms, body lotions, body washes and foot creams—and followed an impressive 10-week test run. During those 10 weeks, 74.4% of Seventh Sense products provided were sold.

In May, the Green Growth announced a partnership with Abercrombie & Fitch to sell CBD-infused Seventh Sense body scrubs, bath bombs, cleansing oils, lotions and lip balms. While initially planned for just 10 A&F locations in Massachusetts, California, Colorado, and Nevada, the partnership was quickly expanded to reach more than 160 stores.

Most recently, at the start of October, Green Growth Brands’ partnership with American Eagle Outfitters, Inc. led to the launch of MOOD, a line of 45 hemp-derived wellness and personal care products. The product line is genderless in its appeal to consumers and features a broad range of personal care products, bath essentials, and aromatherapy items. All MOOD products come from licensed hemp processors in the United States,and if the line is successful, it has the opportunity to grow beyond the first collection.

These partnerships put Green Growth Brands Inc. (CSE:GGB) (OTC:GGBXF) in an enviable position, one that only the most competitive companies in the cannabis space can match.

Through game-changing partnerships with international brands, Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF) and HEXO Corp. (TSX: HEXO) (NYSE: HEXO) are ensuring that they will remain profitable and well-recognized by the consuming public well into the future. Similarly, MedMen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) and OrganiGram Holdings (TSXV: OGI) (NASDAQ: OGI) are putting themselves on good footing in the cannabis retail sector through quick, targeted expansion in key markets.

Combining both these elements is Green Growth Brands Inc. (CSE:GGB) (OTC:GGBXF), which is uniquely positioned to capture an industry that is expected to be worth $20 billion by 2024.

$SRAX Showcases Company Presentation at Leading Consumer & Media Conference

• SRAX presented at the 5th Annual B. Riley Consumer & Media Conference
• CEO and Founder Christopher Miglino discussed the company’s impressive growth and upcoming initiatives during a NetworkNewsWire interview
• BIGtoken offers consumers control of and compensation for data

Digital marketing and consumer data management technology company SRAX Inc. (NASDAQ: SRAX) showcased its presentation yesterday at the 5th Annual B. Riley Consumer & Media Conference at the Sofitel Hotel in New York City (http://nnw.fm/I6Dew). CEO and Founder Christopher Miglino also met with investors and participated in a fireside chat with analyst Mike Crawford during the premier event.

SRAX is expanding its revenue streams by monetizing its datasets through various platforms. SRAX CEO and Founder Christopher Miglino joined Stuart Smith from NetworkNewsWire on September 19, 2019, for an audio interview reviewing the company’s impressive growth pattern during the…

Read more »

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://nnw.fm/SRAX

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

$PBIO Zacks Small Cap Research Initiates Coverage on Pressure BioSciences

SOUTH EASTON, Mass., Oct. 04, 2019 — via OTC PR WIRE – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences industry, today announced that Zacks Small Cap Research (“Zacks SCR”) has initiated coverage on the Company.

Copies of the new Zacks SCR report can be obtained via the following link:

PBIO: Groundwork laid; opportunities abound

Any opinions, judgments, estimates, or forecasts regarding the Company’s historical or predicted performance or operations made by Zacks SCR are theirs alone and do not represent opinions, judgments, estimates, or forecasts of the Company or its management. The Company does not by its reference to the research prepared by Zacks SCR imply its endorsement or adoption of or concurrence with such information, conclusions, or recommendations.

About Zacks Small Cap Research
Zacks Small Cap Research (“Zacks SCR”) is a division of Zacks Investment Research. Zacks SCR coverage specifically looks to focus on small and micro-cap companies that are underfollowed or undervalued by Wall Street.  Our analysts seek to identify and report on these companies, bringing to investors a unique opportunity to gain insight on small cap investments that are believed to be undervalued and well-positioned for future growth.  Our goal is to produce high quality (institutional) research for the small cap portfolio.

About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). Our primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of our pressure-based technologies in the following areas: (1) the use of our recently acquired, patented technology from BaroFold, Inc. (the “BaroFold” technology) to allow entry into the bio-pharma contract services sector, and (2) the use of our recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies.

Forward Looking Statements
This press release contains forward-looking statements. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our or our industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed, implied or inferred by these forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “could,” “would,” “expects,” “plans,” “intends,” “anticipates,” “believes,” “estimates,” “predicts,” “projects,” “potential” or “continue” or the negative of such terms and other comparable terminology. These statements are only predictions based on our current expectations and projections about future events. You should not place undue reliance on these statements. In evaluating these statements, you should specifically consider various factors. Actual events or results may differ materially. These and other factors may cause our actual results to differ materially from any forward-looking statement. These risks, uncertainties, and other factors include, but are not limited to, the risks and uncertainties discussed under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, and other reports filed by the Company from time to time with the SEC. The Company undertakes no obligation to update any of the information included in this release, except as otherwise required by law. Due to rounding, numbers presented throughout this and other documents may not add up precisely to the totals provided and percentages may not precisely reflect the absolute figures.

Investor Contacts:
Richard T. Schumacher, President and CEO, (508) 230-1828 (T)
Nathan P. Lawrence, Ph.D., Senior Consultant, (508) 230-1829 (F)

For more information about PBI and this press release, please click on the following website link:

http://www.pressurebiosciences.com
Please visit us on Facebook, LinkedIn, and Twitter

$OGI Advancing Toward Production Capacity Increase

Organigram Holdings (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, is advancing on its goal to increase its licensed production capacity to 76,000 kilograms per year. An article discussing the company reads, “Additional construction outlined in phase 4B of the company’s expansion plans is on schedule to be completed later this month. The company plans on submitting the licensing amendment for its remaining 16 phase 4B cultivation rooms this month as well. The perimeter of phase 5 of the company’s expansion, which will include an edibles and derivative product facility and more extraction capacity, is also planned for this Health Canada licensing submission (http://cnw.fm/JiP6U).”

To view the full article, visit http://cnw.fm/7PUxA

About Organigram Holdings Inc.

Organigram Holdings is a Toronto Stock Exchange and NASDAQ Global Select-listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada. Organigram is focused on producing the highest-quality, indoor-grown cannabis for patients and adult-recreational consumers in Canada, as well as developing international business partnerships to extend the company’s global footprint. Organigram has also developed a portfolio of legal adult-use recreational cannabis brands including the Edison Cannabis Company, Ankr Organics, Trailer Park Buds and Trailblazer. Organigram’s primary facility is located in Moncton, New Brunswick, and the company is regulated by the Cannabis Act and the Cannabis Regulations (Canada). For more information, visit the company’s website at www.Investors.Organigram.ca.

NOTE TO INVESTORS: The latest news and updates relating to OGI are available in the company’s newsroom at http://cnw.fm/OGRMF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

$CNPOF $RIV.V First Pick-Your-Own Hemp Garden Opens in Maine

October 4, 2019

Khadija Tribble, a community activist, went through the hemp field in Maine with pruning shears and a bag attached on her hips in search of the best hemp plant that has robust foliage, enough flowers, and no bugs. She uses the bulbs to make tinctures and CBD oils for the seniors in her church.

Sheepscot General Farm is located in Whitefield, and it is the second hemp field in the United state accessible to the citizens. It is owned by Ben and Taryn Marcus who are also strawberry farmers. More so, they own a grocery store that doubles as a community center.

To get to the farm, Tribble had to travel for six hours from her home in Salem, Massachusetts. Khadija heard about the farm from friends, and being a firm believer in the hemp plant and its benefits; she immediately knew she had to visit.

After hemp was legalized in 2018 in the U.S, the couple decided to plant the crop. They secured a license to grow 7,000 plants on 3 acres of land.

To make sure that the hemp plant does not exceed the 0.3 percent legal threshold, The Department of Agriculture, Conservation and Forestry tests all the hemp in the licensed farms. Moreover, the hemp grown on Sheepscot is within the legal threshold as it has acceptable traces of THC.

When the flowers picked are dried, cured, and heated at the right temperatures, they are known to give 15-20 percent of CBD, which is used to treat anxiety, insomnia, and pain. At the beginning of this month, Ben and Taryn picked some of the first plants and are planning to sell at the wholesale market.

On Friday, the farm will be open from 2-7 p.m and a guide will be provided to help you pick the best hemp crop to harvest. It will also be open on Saturday and Sunday from 9 a.m to 1 p.m, with an additional class on tincture making on Sunday.

The farm sells the whole plant for $25 per pound, but if you only want branches, then you will pay $35 per pound. According to Ben, it is easy to grow the crop but time-consuming to harvest; therefore, pick-your-own is the best method for harvesting and selling.

A report released last week by New Frontier Data says that the number of issued hemp licenses has quadrupled since it was legalized for cultivation in December.

A national marijuana consulting firm, Brightfield Group, says that Americans are obsessed with CBD-infused products due to a popular belief that CBD helps ease ailments such as anxiety, pain, and depression. In 2018 alone, Americans spent $591 million on CBD products.

The crop has multiple purposes. For instance, builders can use the core for construction, the skin for insulation, and seeds for eating. However, most of the U.S citizens are interested in the CBD oil extracted from the flowers.

In Maine, hemp growers increased from just two farmers to 164 licensed farmers planting thousands of acres. However, it has not been a bed of roses because after the Farm Bill was passed, the Food and Drug Administration prohibited the production of cannabis-infused food.

Analysts believe that hemp industry players like Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) and Earth Science Tech Inc. (OTCQB: ETST) must be very proud of farmers like Ben Marcus and his wife Taryn who have found a novel way to sell their hemp plants.

About HempWireNews

HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

$BHAT Opens Learning Center Featuring Augmented Reality Games, Educational Content

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a producer, developer and operator of augmented reality (“AR”) interactive entertainment games and toys in China, on Thursday announced the opening of its first play-based learning center featuring the company’s AR games and educational content in Xiamen, China. The play-based learning center leverages BHAT’s AR technology to provide an immersive learning experience for children aged 1-7 in subjects including health, language, social and emotional, science and art. The courses offered were designed to help develop various key skills including motor skills, cognitive skills, concentration and memorization, creativity and imagination, social and emotional skills, leadership, teamwork, and understanding rules and solving problems. “We are very excited to open our first AR play-based learning center,” Blue Hat Interactive Entertainment Technology CEO Xiaodong Chen stated in the news release. “We believe our AR technology leads the trend in early childhood education, as the tools and content we develop enrich children’s learning processes with immersive, real-life experiences. Our goal is to cultivate a fun environment, guided by our teachers, that enables young learners to explore their interests as well as develop core skills for school.”

To view the full press release, visit http://nnw.fm/cUbO6

About Blue Hat

Blue Hat Interactive Entertainment Technology is a producer, developer and operator of AR interactive entertainment games and toys in China, including interactive educational materials, mobile games and toys with mobile game features. The company’s interactive entertainment platform creates unique user experiences by connecting physical items to mobile devices, which creates a rich visual and interactive environment for users through the integration of real objects and virtual scenery. Distinguished by its own proprietary technology, Blue Hat aims to create an engaging, interactive and immersive community for its users. For more information, visit the company’s website at ir.bluehatgroup.com.

NOTE TO INVESTORS: The latest news and updates relating to BHAT are available in the company’s newsroom at http://nnw.fm/BHAT

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

$OGI CEO Discusses Rampant Growth in Exclusive NetworkNewsWire Broadcast

NEW YORK, Oct. 03, 2019 — via NetworkNewsAudio – Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI), parent company of Organigram Inc., today announces the broadcast of its audio interview with NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) solution that delivers clients unparalleled visibility, recognition and brand awareness in the investment community.

The interview can be heard at http://nnw.fm/4JBwG

Organigram CEO Greg Engel, a 30-year veteran of the pharmaceuticals, biotech, consumer packed goods and cannabis sectors, joins NNW’s Stuart Smith in an interview that discusses the company’s dramatic growth within Canada and its strategic expansion on a global scale. As one of the original 15 Canadian cannabis companies focused on the medical cannabis space, Organigram has evolved to serve Canada’s adult recreational market and sees significant opportunity in the country’s upcoming legalization of edible and derivative products.

“We are only one of three companies that currently have distribution agreements in all 10 provinces in Canada,” Engel says, noting Organigram has taken a “measured approach” toward growth since its launch as a small, regional player in the western region of Canada.

The company recently uplisted to the Toronto Stock Exchange (TSX) from the TSX Venture Exchange (TSX.V) under the symbol “OGI,” a move that has generated considerable interest from traditional funds and large institutional investors, Engel says. Organigram’s Q3 and fiscal year-to-date results represent some of the strongest operating and financial metrics amongst Canadian licensed producers, placing it in the top tier of the Canadian industry.

Organigram’s focus on indoor, vertical cultivation methods allows the company to maximize its footprint, reduce operating costs and produce the highest quality products, Engel says. The company’s ability to meet its commitments has also been a large part of its success and reputation as a trusted supplier.

“One of the challenges for some companies is over-committing or over-promising on delivery, and that may have led to some practices that put them offside with regulators or from an operations perspective, or with their client base, their customers,” Engel says, adding good corporate governance practices and oversight of operations through a fully independent board of directors also sets Organigram apart from its competitors.

Engel concludes with a look at Organigram’s international expansion plans and a nod to Canada’s soon-to-be-open edibles and derivatives marketplace. The company’s disruptive nano-emulsion technology is being used to create a full range of derivative products including a tasteless, fast-acting and quick offset dissolvable powder for beverages, along with a selection of edibles, including chocolates produced by a team with extensive experience in the space.

Listen to the full interview here: http://nnw.fm/4JBwG

About Organigram Holdings Inc.

Organigram Holdings Inc. is a NASDAQ Global Select and TSX listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada.

Organigram is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the Company’s global footprint. Organigram has also developed a portfolio of legal adult use recreational cannabis brands including The Edison Cannabis Company, Ankr Organics, Trailer Park Buds and Trailblazer. Organigram’s primary facility is located in Moncton, New Brunswick and the Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).

For more information, visit the company’s website at www.Investors.Organigram.ca

NOTE TO INVESTORS: The latest news and updates relating to OGI are available in the company’s newsroom at http://nnw.fm/OGRMF

About NetworkNewsAudio

NetworkNewsAudio (NNA) , a NetworkNewsWire (NNW) Solution, allows you to sit back and listen to market updates, CEO interviews and a Company AudioPressRelease (APR). These audio clips provide snapshots of position, opportunity and momentum. NetworkNewsAudio (NNA) can assist your company by cutting through the overload of information in today’s market, NNA brings its clients unparalleled visibility, recognition and brand awareness. NetworkNewsWire (NNW) is where news, content and information converge. NetworkNewsWire (NNW) is a comprehensive provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW has the unparalleled ability to reach a wide audience of investors, consumers, journalists and the general public with an ever-growing distribution network of more than 5,000 key syndication outlets across the nation.

For more information, visit: www.NetworkNewsAudio.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer.

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.

Corporate Communications:

NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkWire.com

$GWPD Partners with Snoop Dogg to Co-Brand Innovative Cannabis Growing Solution

• GP Solutions is dedicating a series of its innovative and disruptive GrowPod agricultural solutions to the cannabis market through an agreement with rapper and cannabis advocate Snoop Dogg
• The company introduced its ‘Snoop’s Premium Nutrients Pods’ to popular acclaim at the recent CannaCon South convention in Oklahoma City
• Oklahoma is a significant target market, because it has one of the most business-friendly medical marijuana licensing initiatives in the country; GP Solutions expects to open a GrowPod showroom and sales office in Tulsa this month
• The Tulsa facility will also include a training and educational center to teach students about new advances in high-tech agriculture, playing on GrowPods’ advances in cultivating clean and healthy vegetables and herbs for a variety of markets
• GP Solutions also applied for uplisting to the OTCQX Best Market during the past month in an effort to add more value to stockholders’ portfolios

Agricultural technology innovator GP Solutions (OTC: GWPD) recently signed an agreement with rapper, media personality and business builder Snoop Dogg to dedicate some of the company’s innovative and automated micro-farms to a co-branding venture with the ganjapreneur, developing a series of its trademarked GrowPods to be configured as ‘Snoop’s Premium Nutrients Pods’.

The deal is part of a venture through which GP Solutions will become a distributor of Snoop’s Premium Nutrients, a premier product line developed in Holland for the cannabis market…

Read more »

NOTE TO INVESTORS: The latest news and updates relating to GWPD are available in the company’s newsroom at http://cnw.fm/GWPD

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

$LXRP Global CBD Prices Reduce as US Supply Shakes the Market

October 3, 2019

The huge supply of hemp on the global market has triggered price wars between producers and prices have started dropping. Estimates indicate that CBD prices have reduced by close to half within the past 12 months.

Market watchers attribute the surge in industrial hemp supplies to the zeal with which U.S. farmers took to growing this crop after it was legalized by the Agriculture Improvement Act of 2018 (aka the Farm Bill).

Since the harvest season hasn’t yet hit midway within the U.S., there is speculation that CBD prices are likely to drop even further in the coming months when all that harvested hemp enters the finished product market.

To put this trend into perspective, consider the fact that CBD isolate was going for as much as $9,470 a kilo in October last year. In August 2019, this price dropped to about $4,133 a kilo. That is a drop of more than 50 percent in a space of just one year.

Statistics indicate that more than 400,000 acres of land were licensed for industrial hemp cultivation in the U.S. alone this year. While not all that land will actually be cultivated, and even what is cultivated may not all produce the expected harvest, this land area alone towers over the barely 80,000 acres that were put under cultivation of hemp last year.

So many farmers, processors and other players are still entering the hemp arena, and this boom in production is likely to put a downward pressure on the price of different hemp products. For example, farmers may be compelled to sell hemp biomass at a massively discounted price, and processors will no longer command the premium prices that they enjoyed before CBD products become commoditized.

Many farms are still commanding premium rates for their hemp dry matter, and this has created concerns that when prices drop, it will happen in a sudden and potentially spectacular manner unless everyone involved starts toning down their expectations from this recently legalized crop.

Some calculations put the expected hemp dry matter in the U.S. this year at 180 million pounds, which can yield 4.7 million kilos of CBD isolate. If these figures are accurate, then the supply of CBD in the U.S. could be eight times the existing demand for those products.

What this means is that U.S. producers will have to look elsewhere for market, and a drop in the price of CBD products on the European market is testament to the inroads that American companies have made on that continent.

Experts believe that CBD companies like Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and Marijuana Company of America Inc. (OTCQB: MCOA) must now be looking beyond the U.S. market in order to remain profitable long-term.

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

$GGBXF Opens 150th CBD Shop and Provides Progress Update

Positioned to capitalize on holiday shopping season

COLUMBUS, OH, Oct. 3, 2019 – Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) (“GGB” or “the Company”) is pleased to announce that it has opened its 150^th Seventh Sense® Botanical Therapy (“Seventh Sense”) CBD mall-based shop. The first Seventh Sense® shop opened in early February.

Watch Peter Horvath, CEO of GGB, discuss the growth of Seventh Sense from the Polaris Fashion Place location in Columbus, Ohio.

GGB will provide a sales update on the performance of Seventh Sense® shops and eCommerce on its earnings call for fourth quarter and fiscal year 2019 ended June 30. The call will occur on Thursday, October 24th, 2019.  In the interim, the Company would like to share a progress update on the expansion of Seventh Sense®.

• The 150 shops operate across 35 states and are expected to reach up to 200 locations by the start of the holiday shopping season
• To date, nearly 20% of the customers in the consumer database have made a repeat purchase
• Repeat online purchases occur on average every 31 days
• There are over 350 product reviews to date with an average rating of 4.5 stars out of 5
• The Seventh Sense® email consumer database grew 59% over August
• SMS texting to consumers was launched on August 7^th, enrollment grew 178% in the last 30 days
• This month, Seventh Sense® will launch its first national media campaign, heavily focusing on digital and branded media partnerships. Activities will include editorial-focused media placements and unique out-of-home activations in key markets throughout the US.

Seventh Sense® shops retail high-quality botanical therapy CBD-infused personal care and beauty products at affordable prices. The product offering includes over 100 SKUs across bath, body, face, therapeutic, and sleep categories. To shop online, find a list of all retail locations and view consumer product reviews, please visit ShopSeventhSense.com and follow along on Instagram @seventhsensebotanicals.

About Seventh Sense Botanical Therapy
Seventh Sense Botanical Therapy offers CBD-infused botanical body care using the finest ingredients on earth. Crafted with wellness in mind, Seventh Sense aims to make CBD an accessible part of self-care routines across the country. Discover the magic of CBD at shops across the country and online at ShopSeventhSense.com and on Instagram @seventhsensebotanicals.

About Green Growth Brands Inc.
Green Growth Brands creates remarkable experiences in cannabis and CBD. Led by CEO Peter Horvath and a leadership team of consumer-focused retail experts, the company’s brands include CAMP, Seventh Sense Botanical Therapy, The+Source, Green Lily, and Meri + Jayne. The Company also has a licensing agreement with the Greg Norman™ Brand to develop a line of CBD-infused personal care products designed for active wellness. Already driving the strongest sales per square feet in the cannabis industry, GGB is expanding its cannabis operations throughout the U.S its CBD presence at ShopSeventhSense.com, in malls across the country, at DSW and Abercrombie & Fitch stores—and that’s just the beginning. Learn more about the vision at  GreenGrowthBrands.com.

Cautionary Statements:

Certain information in this news release constitutes forward-looking statements under applicable securities law. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “intend”, “forecast” and similar expressions.   Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving medical and recreational marijuana; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favorable terms; the marijuana industry in the United States, income tax and regulatory matters; the ability of the Company to implement its business strategies; competition; currency and interest rate fluctuations and other risks, including those factors described under the heading “Risks Factors” in the Company’s Annual Information Form dated November 26, 2018, which is available on the Company’s issuer profile on SEDAR.

Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. The forward-looking statements contained in this release, including, but not limited to, the Company’s ability to execute on its growth strategy, the Company’s vision to become a multi-state operator with retail stores exceeding certain financial thresholds is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

This announcement does not constitute an offer, invitation or recommendation to subscribe for or purchase any securities and neither this announcement nor anything contained in it shall form the basis of any contract or commitment. In particular, this announcement does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States, or in any other jurisdiction in which such an offer would be illegal.

The securities referred to herein have not been and will not be registered under the Securities Act of 1933, as amended (the “Securities Act”), or under the securities laws of any state or other jurisdiction of the United States and may not be offered or sold, directly or indirectly, within the United States, unless the securities have been registered under the Securities Act or an exemption from the registration requirements of the Securities Act is available.

$TGODF Processing Challenges Could Cause Billions in Losses as Hemp Rots on Farms

October 3, 2019

Farmers in the United States have adopted the cultivation of hemp due to its increased prospects and abandoned mainstream crops such as soybeans which are ensnared in trade conflicts with other countries such as China. Therefore, in search of profitable alternatives, farmers have engaged in the widespread commercial planting of hemp.

Cannabidiol (CBD), a hemp compound which is a nonpsychoactive ingredient of marijuana, is at the center of the wellness industry in which beauty products and dietary supplement makers are using cannabidiol in the manufacturing process.

The Food and Drug Administration has not cleared the production of CBD infused foods and drinks, even though Congress legalized the growing of hemp.  A California based manufacture of cannabidiol extraction machines, Delta Separations, estimates that $7.5 billion in hemp may spoil on farms.

Roger Cockroft, CEO of Delta Separations, attributed the estimated loss to lack of enough infrastructure to support processing the crop. He further added that the reluctance of banks to provide marijuana-linked businesses with loans is another prospect curbing the expansion process.

In 2018, Congress cleared the way for expanded planting of hemp after industrial hemp and CBD were legalized. According to the gathered data by the Department of Agriculture, farmers planted 142,691 acres of hemp this year. However, according to the Vote Hemp advocacy group, some farmers may be withholding the exact acreage planted from the government; therefore, the group estimates that the total acres planted to be 230,000.

An economist at Whitney Economics, Beau Whitney said the government is playing catch up with the hemp market as it is developing and expanding at a rapid rate.

A farmer in Delavan, Illinois, David Diekhoff has 1500 acres of hemp together with corn and soybeans.  Diekhoff plans to look for a customer before harvesting the flowers from his plants.

Whitney Economics carried out a survey in July which found that 65% of hemp growers did not manage to find buyers for their crops. This forced them to enter into a contract with companies that are on the brink of financial difficulties.

The director of hemp markets at PanXchange says in the last few months, the price of some CBD products has dropped on the platform. For instance, the cost of winterized hemp oil is one-fifth of its January cost. The downward pressure on price may result in no payment for the farmers since the small processing companies will be having financial problems.

For the CBD extracted to be valid for use, farmers need to follow a specific order when harvesting hemp. The crop has to be dried after harvesting and before the extraction of CBD. The Whitney Economist says that since the farmers have no experience in harvesting the plant, they may leave it in the fields to dry, where it will be rained on and get mold — resulting in little or no CBD in the market which will eventually cause an increase in price.

In Yuma County, Arizona, Integrated CBD, which can process 1240 acres of hemp, has lined up buyers of CBD from the cosmetic and food industries.

In a phone interview, the CEO of Scottsdale, Patrick Horsman, said that the hemp business model requires growing, drying and extraction to work in cohesion. Therefore, as a farmer, you should be concerned if you do not have the processing and drying capabilities.

In another phone interview with the Executive Director of the Industrial Hemp Association in North Carolina, Blake Butler, said that many farmers shifted to hemp growth anticipating huge CBD profits. He further added that when farmers start to grow hemp for other uses, the industry will even out.

It would be good to hear what remedies hemp companies like The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) and Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) have for the current shortage of hemp processing facilities in the U.S.

About HempWireNews

HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

$CNPOF $RIV.V Announces Details Surrounding TerrAscend Canada Investment

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today provided details surrounding its investment in connection with a financing announced October 2, 2019. According to the update, Canopy Rivers has acquired ownership and control over (i) $13,243,000 principal amount of unsecured convertible debentures of TerrAscend Canada Inc. (the “Debentures”); and (ii) 333,723 common share purchase warrants of TerrAscend (the “Warrants”). The Debentures’ principal amount is convertible into fully paid and non-assessable common shares or exchangeable shares of TerrAscend at the holder’s option, or upon the occurrence of certain events, at a conversion price of $5.95 per share. The Debentures mature on October 2, 2024 and bear a per-annum interest rate of 6%.

To view the full press release, visit http://cnw.fm/j5njG

About Canopy Rivers Inc.

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers identifies strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth Corporation (TSX: WEED, NYSE: CGC) and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem. For more information, visit the company’s website at www.CanopyRivers.com.

NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://cnw.fm/CNPOF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

$SRAX BIGtoken Platform Rewards Consumers for Opting to Release Data

SRAX (NASDAQ: SRAX), through its proprietary BIGtoken platform, has developed a consumer-managed data marketplace where consumers can own their own data and earn rewards for the release of that data. An article discussing the company reads, “Once consumers grant consent to allow businesses access to their data, BIGtoken sells that access in the form of anonymized segments; the platform can also remove access at any time. Once consent is granted, a mutually beneficial relationship is formed between SRAX and its customers. BIGtoken offers high-quality data that enables advertisers, for a premium, to have access to consumer-verified information for their campaigns. Moreover, consumers who sell access to their digital data receive compensation in the form of points, which they can redeem for cash or gift cards. . . . SRAX is growing numerous recurring revenue streams through its different platforms. Along with its BIGtoken platform, the company also offers its SRAX Platform, SRAX Social, SRAX IR, SRAX Auto, SRAX Fan and SRAX Shopper. SRAX is building technology that is creating proprietary data, in turn fostering long-term, recurring revenue.”

To view the full article, visit http://nnw.fm/Ta18y

About SRAX Inc.

SRAX is a digital-marketing and consumer-data-management technology company. SRAX’s technology unlocks data to reveal a brand’s core consumers and the characteristics of those consumers across marketing channels. Monetizing its data sets, SRAX is growing multiple recurring revenue streams through its various platforms. Through the BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby offering everyone in the internet ecosystem choice, transparency and compensation. SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform. For more information, visit the company’s website at www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://nnw.fm/SRAX

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

$POAI Sells 10 STREAMWAY® Systems to Prominent Teaching Hospital

• Skyline Medical, a subsidiary of POAI, continues to forge the standardization of waste fluid management with its sale of 10 systems in Rochester, NY.
• The STREAMWAY System transforms the collection, measurement and disposal of healthcare waste fluid making it safer, easier and environmentally friendly.   
• POAI continues to impress, innovate with disruptive technological advancements in the healthcare industry.

MINNEAPOLIS, Oct. 02, 2019 — Predictive Oncology Inc. (NASDAQ: POAI) today announced that its Skyline Medical division, producer of the FDA-approved and CE-marked STREAMWAY® System for automated, direct-to-drain medical fluid disposal, has completed the sale of ten systems to the foremost teaching and research hospital in upstate New York.  According to U.S. News and World Report, the 800+ bed hospital has among the best clinical programs in the country.  The sale surpasses the company’s largest single hospital sale to date and is expected to generate 6000 procedures annually.

Skyline Medical’s patented, FDA-approved STREAMWAY System is the first truly continuous, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, surgery, urology, and cystoscopy procedures. The system has revolutionized the way healthcare facilities handle potentially infectious waste by connecting directly to facilities’ plumbing systems in order to automate the collection, measurement, and disposal of waste fluids. This minimizes human intervention, creating a safer system with improved compliancy with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines (http://nnw.fm/oaC78).

Additionally, by eliminating plastic waste in the form of canisters and evacuated bottles, the STREAMWAY System reduces overhead costs and minimizes environmental impact, eliminating the approximately 50 million potentially disease-infected canisters that wind up in landfills each year in the United States (http://nnw.fm/oQQ8d).

About Predictive Oncology Inc.

Predictive Oncology Inc. (NASDAQ: POAI) operates in two business areas: first, applying artificial intelligence to personalized medicine and drug discovery to provide personalized medicine solutions for patients and clinicians as well as clients in the pharmaceutical, diagnostic, and biotech industries, and second, production of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal.

Forward-Looking Statements

Certain of the matters discussed in the press release contain forward-looking statements that involve material risks to and uncertainties in the Company’s business that may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include (i) risks related to the recent merger with Helomics, including the fact that the combined company will not be able to continue operating without additional financing; possible failure to realize anticipated benefits of the merger; costs associated with the merger may be higher than expected; the merger may result in disruption of the Company’s and Helomics’ existing businesses, distraction of management and diversion of resources; and the market price of the Company’s common stock may decline as a result of the merger; (ii) risks related to our partnerships with other companies, including the need to negotiate the definitive agreements; possible failure to realize anticipated benefits of these partnerships; and costs of providing funding to our partner companies, which may never be repaid or provide anticipated returns; and (iii) other risks and uncertainties relating to the Company that include, among other things, current negative operating cash flows and a need for additional funding to finance our operating plan; the terms of any further financing, which may be highly dilutive and may include onerous terms; unexpected costs and operating deficits, and lower than expected sales and revenues; sales cycles that can be longer than expected, resulting in delays in projected sales or failure to make such sales; uncertain willingness and ability of customers to adopt new technologies and other factors that may affect further market acceptance, if our product is not accepted by our potential customers, it is unlikely that we will ever become profitable; adverse economic conditions; adverse results of any legal proceedings; the volatility of our operating results and financial condition; inability to attract or retain qualified senior management personnel, including sales and marketing personnel; our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; Predictive Oncology’s ability to implement its long range business plan for various applications of its technology; Predictive Oncology’s ability to enter into agreements with any necessary marketing and/or distribution partners and with any strategic or joint venture partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of Predictive Oncology’s technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company’s reports filed with the SEC, which are available for review at www.sec.gov. This is not a solicitation to buy or sell securities and does not purport to be an analysis of Predictive Oncology’s financial position. See Predictive Oncology’s most recent Annual Report on Form 10-K, and subsequent reports and other filings at www.sec.gov.

Contact
Bob Myers, Predictive Oncology Inc.
651-389-4800

$OGI 2020 World Ag Expo to Debut Hemp Pavilion

October 2, 2019

Globally, industrial hemp is used in more than 250,000 products, and interest in this versatile plant doesn’t seem to have peaked just yet. For the first time, the World Ag Expo is going to feature a hemp pavilion where there will be space for exhibitors and a stage for seminars during the expo due to take place in February 2020.

The World Ag Expo held in California each year is seen as the defacto signal that the new agricultural season is about to begin, and that is why the organizers see this event as the best time to hold seminars and allow exhibitors to showcase what they have about hemp.

Now heading into its 53rd year, the World Ag Expo is undeniably the largest outdoor agricultural trade show organized annually in the world. The statistics of the last one held in 2019 are staggering.

For example, 102,800 people attended the event. These people were from 48 states across the U.S. and 65 countries. 1,400 exhibitors took part in the most recent event and next year is expected to attract even more. The available exhibition space is a mind-boggling 2.6 million square feet.

The expo is a platform for networking, business and education in one of the most productive agricultural counties in the United States.

During the 2019 World Ag Expo, the organizers worked and included six hemp panels to educate prospective industrial hemp farmers about the different options available to them. Each of the six stands was packed to capacity during each panel session, and this confirmed to the organizers that the expo was a good event at which hemp farmers can be given all the information that they need about this newly legalized crop.

While the crop has great potential, there are a number of growing pains that farmers have to contend with before they can reap from their harvest. These pitfalls include challenges in getting certified seed, the need for market contracts before a farmer puts the plants in the ground and the difficulties in getting financing from banks are some of the key obstacles that farmers have to find solutions to.

Those same issues will form the core of the discussions conducted during the seminars in the hemp pavilion next year. Exhibitors will also display some of the solutions available to the hemp industry.

Exhibition space in the hemp pavilion is now on sale and bookings can be made through the event organizers.

It is believed that events such as the World Ag Expo provide hemp companies like Neutra Corp. (OTCQB: NTRR) and Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) with opportunities that can extend their reach beyond the markets where their products had been known.

About HempWireNews

HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

$GGBXF AI Analytics Report Reveals Drivers of the CBD Craze

October 2, 2019

According to an analysis performed by Tastewise, an artificial intelligence (AI)-powered food trend analysis company, people are searching for functional benefits in what they eat and drink, and that is why cannabidiol (CBD) has picked traction so quickly among consumers.

Tastewise was founded by a former executive at Google called Alon Chen, together with Eyal Gaon. The company analyzes billions of what they call “data points” taken from social media, home recipes and restaurant menus.

They use the findings of such analyzes to provide valuable insights on the ingredients playing a key role in shaping the food and beverages industry.

In its latest report, Tastewise highlights CBD and other ingredients that are having a monumental role in shaping the food and beverages landscape.

The report reveals that a third of all online conversations around food focus on the functional or health benefits of those foods. This could explain why food ingredients where health claims are made on the packaging attract more attention than those that don’t list any health claims.

Specifically for CBD, the report written by Tastewise indicates that there was a 286 percent increase in the number of people who consumed CBD products in order to improve their gut health.

In the last year, the number of people who wanted CBD products in order to improve their sleep rose by 201 percent, at least according to the data points tracked by the analytics company.

The number of people who discussed cannabidiol (CBD) as a food ingredient that improves the immune system increased by 138 percent from last year while those who wanted it for an energy boost increased by 70 percent over the same period.

It should be noted that most CBD on the market is extracted from industrial hemp, so it isn’t surprising that hemp oil registered a whopping 925 percent increase in the number of mentions by consumers looking to use it as a way to manage stress.

Other ingredients that were highlighted in this report include pea protein which saw a 542 percent rise in mentions as a wellness ingredient and celery whose user engagement statistics increased by 187 percent.

Experts say that this report shows how much pressure the FDA is going to be faced with as it formulates regulations for CBD products. Health claims seem to be integral to the success of this industry, and it would be enlightening to hear what CBD companies like Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) and Hemptown USA suggest as ways to keep the industry growing while making limited claims about the health benefits of this cannabinoid.

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

$GWPD Coverage Initiated via NetworkNewsWire

NEW YORK, Oct. 02, 2019 — via NetworkWire – GP Solutions Inc. (OTC: GWPD), a leading developer of highly innovative, automated micro-farms under the trade name “GrowPods,” today announces it has selected the corporate communications expertise of NetworkNewsWire (“NNW”).

GP Solutions provides innovative, environmentally optimized systems for growing high quality specialty leafy crops without pesticides, harmful chemicals, pathogens or contaminants. Each GrowPod utilizes the most recent technology using PROLIFIC soil-less growth medium or hydroponic growing technology to allow year-round growing capable of producing predictable yields and maximizing growers return on investment.

Headquartered in Colton, California, GP Solutions produces custom container farms for growers, farmers, restaurants, hotels, casinos, entrepreneurs and investors located throughout North America.

NNW is a multifaceted financial news and publishing company that delivers a new generation of social communication solutions, news aggregation and syndication, and enhanced news release services. NNW’s strategies help public and private organizations find their voice and build market visibility. As part of the Client-Partner relationship with GP Solutions, NNW will leverage its investor-based distribution network of over 5,000 key syndication outlets, various newsletters, social media channels, blogs, and other outreach tools to generate greater brand awareness for the company.

“The engineering behind GP Solutions’ GrowPod container farms provides year-round farming anywhere in the world. This capability addresses the issues of providing a clean and safe food supply, reducing world hunger, maximizing crop yields, and offering a rapid and inexpensive pathway for entrepreneurs and businesses to enter multiple agricultural sectors,” states Sherri Franklin, Director of Client Solutions for NNW. “As the company focuses on expanding its market reach and application, we will execute a corporate communications campaign that places its strategy and accomplishments in front of the investment community.”

About GP Solutions

GrowPod Solutions, Inc. is the developer of highly innovative automated micro-farms trade named “GrowPods.” GrowPods are a modular, stackable and mobile vertical growing environment specifically engineered to maximize yield and automation. GP Solutions offers a fully insulated, food-grade shipping container specifically modified to provide the optimum controlled environment for growing a wide range of horticultural and agricultural products in all environments and climates. With the company’s combination of hydroponic and certified organic soil systems, clients can produce a significantly higher yield that grows faster, healthier and more consistently. For more information, visit the company’s website at www.GrowPodSolutions.com.

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets, (3) enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, please visit: https://www.NetworkNewsWire.com.

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer.

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.

Corporate Communications:

NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkWire.com